Montelukast Prescribing at PARK VIEW SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
495
Total Quantity
16.0K
NHS Cost
£767
vs National Avg
-27.7%
PARK VIEW SURGERY prescribed 495 items of Montelukast over the last 12 months at a cost of £767 to the NHS. This is 27.7% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
36
Jun 2026
42
Jun 2026
35
Jun 2026
38
Jun 2026
37
Jun 2026
38
Jun 2026
52
Jun 2026
37
Jun 2026
44
Jun 2026
47
Jun 2026
44
Jun 2026
45
Prescribing Details
| Total Items | 495 |
|---|---|
| Total Quantity | 16,047 |
| Total NHS Cost | £767 |
| Presentations | 4 different forms |
| vs National Average | -27.7% |
Montelukast Prescribing Comparison
| This practice | 495 items |
|---|---|
| National average per practice | 685 items |
| Difference | -27.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.